New medication given every 1-3 months may slash stubborn high cholesterol
November 13, 2023
November 13, 2023
DALLAS, Texas, Nov. 13 [Category: Health Care] -- The American Heart Association issued the following news release:
Research Highlights:
While currently available PCSK9 inhibitor medications to lower cholesterol must be administered every few weeks by injection, a new, investigational PCSK9 inhibitor called recaticimab safely lowered bad cholesterol more than 50% when injected every 1-3 months, depending on dose.
In the study, recaticimab also reduced level . . .
Research Highlights:
While currently available PCSK9 inhibitor medications to lower cholesterol must be administered every few weeks by injection, a new, investigational PCSK9 inhibitor called recaticimab safely lowered bad cholesterol more than 50% when injected every 1-3 months, depending on dose.
In the study, recaticimab also reduced level . . .